Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medistim | Oslo | Salute | Attrezzature e forniture medicali | 3,33 Mrd NOK | 31,9x | -3,18 | 182 NOK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,8% Rialzo | Fai l’upgrade a Pro+ | |
Nordhealth As | Oslo | Salute | Attrezzature e forniture medicali | 2,65 Mrd NOK | -25,3x | -0,9 | 36 NOK | 7,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,3% Rialzo | Fai l’upgrade a Pro+ | |
Nykode Therapeutics | Oslo | Salute | Ricerca medica e biotecnologica | 1,52 Mrd NOK | -4,5x | -0,15 | 4,58 NOK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Photocure | Oslo | Salute | Prodotti farmaceutici | 1,42 Mrd NOK | 110,8x | 0,84 | 52,50 NOK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Vistin Pharma ASA | Oslo | Salute | Prodotti farmaceutici | 1,27 Mrd NOK | 18,6x | 0,05 | 28,60 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arcticzymes Tech | Oslo | Salute | Ricerca medica e biotecnologica | 924,39 Mln NOK | 63,8x | 41,48 | 18,10 NOK | 2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 36,1% Rialzo | Fai l’upgrade a Pro+ | |
Gentian Diagnostics | Oslo | Salute | Attrezzature e forniture medicali | 694,01 Mln NOK | -344,6x | -4,14 | 44,80 NOK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 45% Rialzo | Fai l’upgrade a Pro+ | |
Omda AS | Oslo | Salute | Attrezzature e forniture medicali | 649,86 Mln NOK | 8,4x | 0,04 | 30,40 NOK | -5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 43,5% Rialzo | Fai l’upgrade a Pro+ | |
Navamedic | Oslo | Salute | Prodotti farmaceutici | 549,31 Mln NOK | 21,9x | 1,15 | 31,10 NOK | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 48,2% Rialzo | Fai l’upgrade a Pro+ | |
ContextVision AB | Oslo | Salute | Attrezzature e forniture medicali | 396,12 Mln NOK | 15,4x | -0,56 | 5,20 NOK | -3,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,1% Rialzo | Fai l’upgrade a Pro+ | |
Bergenbio | Oslo | Salute | Ricerca medica e biotecnologica | 386,18 Mln NOK | -1,8x | -0,03 | 9,88 NOK | 2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lytix Biopharma AS | Oslo | Salute | Ricerca medica e biotecnologica | 364,14 Mln NOK | -4,3x | -0,24 | 6,92 NOK | -5,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
INIFY Laboratories | Oslo | Salute | Attrezzature e forniture medicali | 361,89 Mln NOK | 7,10 NOK | -11,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Arctic Bioscience AS | Oslo | Salute | Prodotti farmaceutici | 329,80 Mln NOK | -7,2x | 0,33 | 12,50 NOK | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,2% Rialzo | Fai l’upgrade a Pro+ | |
Lifecare | Oslo | Salute | Ricerca medica e biotecnologica | 320,26 Mln NOK | -6,6x | 1,18 | 1,60 NOK | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Thor Medical | Oslo | Salute | Ricerca medica e biotecnologica | 286,53 Mln NOK | -21,8x | 1,21 NOK | 4,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Exact Therapeutics AS | Oslo | Salute | Ricerca medica e biotecnologica | 184,46 Mln NOK | -4,6x | 0,26 | 5,75 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Observe Medical | Oslo | Salute | Attrezzature e forniture medicali | 97,78 Mln NOK | -1x | -0,03 | 0,40 NOK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Codelab Capital AS | Oslo | Salute | Attrezzature e forniture medicali | 79,98 Mln NOK | 0,22 NOK | -4,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
PCI Biotech | Oslo | Salute | Ricerca medica e biotecnologica | 64,57 Mln NOK | -4,1x | -0,09 | 1,73 NOK | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ultimovacs | Oslo | Salute | Ricerca medica e biotecnologica | 58,83 Mln NOK | -0,5x | -0,09 | 1,73 NOK | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SoftOx Solutions | Oslo | Salute | Ricerca medica e biotecnologica | 37,07 Mln NOK | -0,1x | -0,01 | 0,02 NOK | 7,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Circio Holding | Oslo | Salute | Ricerca medica e biotecnologica | 17,16 Mln NOK | 0,6x | 0,02 | 0,70 NOK | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |